XML 216 R161.htm IDEA: XBRL DOCUMENT v3.10.0.1
Renasant Corporation (Parent Company Only) Condensed Financial Information - Statements of Cash Flows (Details) - USD ($)
$ in Thousands
3 Months Ended 12 Months Ended
Dec. 31, 2018
Sep. 30, 2018
Jun. 30, 2018
Mar. 31, 2018
Dec. 31, 2017
Sep. 30, 2017
Jun. 30, 2017
Mar. 31, 2017
Dec. 31, 2018
Dec. 31, 2017
Dec. 31, 2016
Operating activities                      
Net income $ 44,420 $ 31,964 $ 36,710 $ 33,826 $ 16,511 $ 26,421 $ 25,284 $ 23,972 $ 146,920 $ 92,188 $ 90,930
Adjustments to reconcile net income to net cash provided by operating activities:                      
Gain on sale of securities                 16 (148) (1,186)
Decrease (increase) in other assets                 44,044 (6,620) 10,136
(Decrease) increase in other liabilities                 (41,954) (12,572) (16,694)
Net cash provided by operating activities                 77,406 201,561 163,797
Investing activities                      
Net cash (paid) received in acquisition                 153,502 41,685 25,263
Net cash (used in) provided by investing activities                 (498,581) 75,142 (351,993)
Financing activities                      
Cash paid for dividends                 (43,614) (34,416) (29,734)
Cash received on exercise of stock-based compensation                 201 173 415
Excess tax benefits from exercise of stock options                 0 0 2,771
Repurchase of shares in connection with stock repurchase program                 (7,062) 0 0
Repayment of long-term debt                 (849) (170,240) (47,230)
Proceeds from issuance of long-term debt                 0 0 98,385
Proceeds from equity offering                 0 0 84,105
Net cash provided by (used in) financing activities                 708,833 (301,474) 282,849
Net increase (decrease) in cash and cash equivalents                 287,658 (24,771) 94,653
Cash and cash equivalents at beginning of year       281,453       306,224 281,453 306,224 211,571
Cash and cash equivalents at end of year 569,111       281,453       569,111 281,453 306,224
Renasant Corporation                      
Operating activities                      
Net income                 146,920 92,188 90,930
Adjustments to reconcile net income to net cash provided by operating activities:                      
Gain on sale of securities                 0 0 (1,186)
Equity in undistributed net income of bank subsidiary                 (103,619) (65,970) (65,591)
Amortization/depreciation/accretion                 160 656 560
Decrease (increase) in other assets                 3,381 (1,069) (556)
(Decrease) increase in other liabilities                 (171) (2,291) 564
Net cash provided by operating activities                 46,671 23,514 24,721
Investing activities                      
Purchases of securities held to maturity and available for sale                 0 0 (1,380)
Sales and maturities of securities held to maturity and available for sale                 1,052 1,555 6,101
Investment in subsidiaries                 0 (25,000) (75,000)
Net cash (paid) received in acquisition                 (34,836) 4,834 0
Other investing activities                 423 (54) 0
Net cash (used in) provided by investing activities                 (33,361) (18,665) (70,279)
Financing activities                      
Cash paid for dividends                 (43,614) (34,416) (29,734)
Cash received on exercise of stock-based compensation                 201 173 415
Excess tax benefits from exercise of stock options                 0 0 2,771
Repurchase of shares in connection with stock repurchase program                 (7,062) 0 0
Repayment of long-term debt                 0 (10,310) 0
Proceeds from issuance of long-term debt                 0 0 98,127
Proceeds from equity offering                 0 0 84,105
Other financing activities                 (93) 310 0
Net cash provided by (used in) financing activities                 (50,568) (44,243) 155,684
Net increase (decrease) in cash and cash equivalents                 (37,258) (39,394) 110,126
Cash and cash equivalents at beginning of year       $ 81,839       $ 121,233 81,839 121,233 11,107
Cash and cash equivalents at end of year $ 44,581       $ 81,839       $ 44,581 $ 81,839 $ 121,233